These allow many people to take their HIV treatment in one tablet, once a day. These one-pill-a-day HIV treatments are often known as ‘single-tablet regimens’ or STRs. In the UK, these single-tablet ...

The new regimen, dubbed Dovato, is approved in adults and adolescents above 12 years of age with HIV-1, and is based on a combination of dolutegravir and lamivudine given as a single pill once daily.

The combination of tenofovir, FTC, and efavirenz might soon be available in a single pill. For years, effective antiretroviral treatment has required HIV-positive patients to take a large handful ...

The phase III MK-8591A-051 and MK-8591A-052 studies evaluated DOR/ISL (100 mg/0.25 mg) in adults with HIV-1 infection who are on different antiretroviral therapy regimens like baseline ...

A small French biotech is trumpeting results from a trial suggesting its developmental drug could be used as part of an HIV cure. The phase 2a trial of AbiVax’s ABX464 pill is small but confirms ...